These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4908885)

  • 1. Thyroid-hormone enhancement of imipramine in nonretarded depressions.
    Wilson IC; Prange AJ; McClane TK; Rabon AM; Lipton MA
    N Engl J Med; 1970 May; 282(19):1063-7. PubMed ID: 4908885
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of imipramine antidepressant activity by thyroid hormone.
    Prange AJ; Wilson IC; Rabon AM; Lipton MA
    Am J Psychiatry; 1969 Oct; 126(4):457-69. PubMed ID: 4185164
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormonal potentiation of imipramine and ECT in primary depression.
    Feighner JP; King LJ; Schuckit MA; Croughan J; Briscoe W
    Am J Psychiatry; 1972 Apr; 128(10):1230-8. PubMed ID: 4552204
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine.
    Coppen A; Whybrow PC; Noguera R; Maggs R; Prange AJ
    Arch Gen Psychiatry; 1972 Mar; 26(3):234-41. PubMed ID: 4551048
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
    Thase ME; Kupfer DJ; Jarrett DB
    J Clin Psychiatry; 1989 Oct; 50(10):385-8. PubMed ID: 2676995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications.
    Prange AJ; Wilson IC; Knox A; McClane TK; Lipton MA
    Am J Psychiatry; 1970 Aug; 127(2):191-9. PubMed ID: 5473147
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of a thyroid hormone to accelerate the action of imipramine.
    Prange AJ; Wilson IC; Lipton MA; Rabon AM; McClae TK; Knox AE
    Psychosomatics; 1970; 11(5):442-4. PubMed ID: 5470670
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled study of single-dose administration of imipramine pamoate in endogenous depression.
    Miller WC; Marcotte DB; McCurdy L
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):700-6. PubMed ID: 4201314
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of amitriptyline by thyroid hormone.
    Wheatley D
    Arch Gen Psychiatry; 1972 Mar; 26(3):229-33. PubMed ID: 4551047
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of drug effects in newly hospitalized depressives.
    Rockliff BW
    Dis Nerv Syst; 1971 Aug; 32(8):532-7. PubMed ID: 4937543
    [No Abstract]   [Full Text] [Related]  

  • 11. Amoxapine, imipramine and placebo in depressive illness.
    Smith RC
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):346-53. PubMed ID: 809247
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketipramine fumarate as compared to imipramine in depressed outpatients.
    Park S; Glick B; Floyd A; Gershon S
    Curr Ther Res Clin Exp; 1971 May; 13(5):322-5. PubMed ID: 4998396
    [No Abstract]   [Full Text] [Related]  

  • 13. Amoxapine and imipramine: a double-blind study in depressed patients.
    Sathananthan GL; Matz R; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):919-22. PubMed ID: 4203576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dibenzepin in depression. A controlled clinical trial].
    Vinar O; Taussigová D
    Act Nerv Super (Praha); 1967 Nov; 9(4):359-61. PubMed ID: 4889063
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined drug treatment of newly hospitalized, acutely ill psychiatric patients.
    Hanlon TE; Ota KY; Agallianos DD; Berman SA; Bethon GD; Kobler F; Kurland AA
    Dis Nerv Syst; 1969 Feb; 30(2):104-16. PubMed ID: 4388249
    [No Abstract]   [Full Text] [Related]  

  • 16. The NIMH collaborative depression studies--a progress report.
    Raskin A
    Psychopharmacol Bull; 1972 Jul; 8(3):55-9. PubMed ID: 4559524
    [No Abstract]   [Full Text] [Related]  

  • 17. Myxedematous madness without myxedema. Selective defect of TSH release on TRF loading in a young woman with a history of severe depressive illness cured with thryoid hormone replacement therapy.
    Nordgren L; von Schéele C
    Acta Med Scand; 1976; 199(3):233-6. PubMed ID: 816176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy resistant depressions. Methodological problems. Contributions to methodical questions and animal-experimental aspects.
    Pichot P
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):80-4. PubMed ID: 4438427
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of depression in the aged with gerovital H3: clinical efficacy and neurophysiological effects.
    Zung WW; Gianturco D; Pfieffer E
    Psychopharmacol Bull; 1976 Apr; 12(2):50-1. PubMed ID: 769036
    [No Abstract]   [Full Text] [Related]  

  • 20. Thioridazine as an antidepressant.
    Practitioner; 1972 Jul; 209(249):95-8. PubMed ID: 4557482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.